We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Antioxidants Treat Smith-Lemli-Opitz Syndrome

News   Feb 05, 2018 | By Ellen Goldbaum for University at Buffalo

 
Evidenced-Based Antioxidant Therapy Prevents Vision Loss Caused by Smith-Lemli-Opitz Syndrome

Light microscopy images of retinas from animal model of Smith-Lemli-Opitz Syndrome (SLOS). Treatment with antioxidant combination therapy (right) preserved normal retinal structure and prevented degeneration and death of photoreceptor cells (rods and cones). Credit: Steven Fliesler

 
 
 

RELATED ARTICLES

Disease Risk Seen in Disrupted Biological Clock, USC Study Shows

News

A clash between modern lifestyles and circadian rhythms can lead to the development of obesity and breast cancer, USC scientist says.

READ MORE

A Sobering Conclusion: Adult Hearts Do Not Contain Stem Cells

News

While cardiac stem cells (CSC) are of great interest for regenerative intervention, the significance of these populations remains heavily debated. A study published in PNAS did not find any evidence for the existence of a quiescent CSC population.

READ MORE

A New Physiological Index for Assessing Mental Workload?

News

The fractal dimension of pupil dilation could be used as a new physiological index to measure the workload in a multitasking environment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE